Philippines Clinical Nutrition for Diabetes Care Market Analysis

Philippines Clinical Nutrition for Diabetes Care Market Executive Summary

The Philippines Clinical Nutrition for Diabetes Care Market is at around $4.73 Mn in 2023 and is projected to reach $6.78 Mn in 2030, exhibiting a CAGR of 5.28% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients control blood sugar, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and improve overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Zemaica Healthcare, Sanofi is known for its extensive portfolio of medications, including those essential for diabetes care. Zuellig Pharma, Nestlé Health Science, and Novo Nordisk are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

Market Dynamics

Market Growth Drivers

Expansion of Healthcare Infrastructure: The Philippines is working to improve its healthcare infrastructure and coverage through initiatives like the Universal Health Care Act. It aims to provide all Filipinos with equitable access to high-quality health services, including those related to diabetes care. This will enable more people with diabetes to access specialized clinical nutrition services as part of their comprehensive diabetes management.

Increasing Prevalence of Diabetes: Diabetes has progressively increased globally in recent decades, owing to causes such as sedentary lifestyles, bad food habits, and rising obesity rates. The Philippines has a significant diabetic population, As per the International Diabetes Federation, about 7.5% of adults have diabetes. There is growing demand for effective nutrition interventions to manage blood sugar levels and prevent complications, driving market growth

Limited Access to Diabetes Care: Many Filipinos with diabetes face challenges in accessing proper diabetes management and care due to insufficient healthcare financing, fragmented referral systems, and high out-of-pocket costs. This creates demand for clinical nutrition products and services.

Market Restraints

High Cost of Specialized Products: Specialized diabetic nutrition products can be expensive compared to regular food options. This can be a major barrier for low-income families and those in remote areas with limited healthcare resources This highlights the financial burden associated with the high cost of specialized therapeutic foods used to treat diabetes.

Lack of Access to Registered Dietitians: There is a shortage of registered dietitians or healthcare professionals trained in clinical nutrition for diabetes. This can limit access to proper consultations and personalized plans, hindering the effectiveness of these interventions.

Cultural Preferences: Traditional Filipino cuisine often relies heavily on white rice and refined carbohydrates. This can make it challenging for some patients to adopt a diabetic diet that aligns with their cultural food preferences

Regulatory Landscape and Reimbursement Scenario

The Philippine Food and Drug Administration (FDA) likely plays a role in regulating the manufacturing, marketing, and labeling of any specialized diabetic nutritional products. They would ensure the safety and proper labeling of ingredients and claims. The Philippine Association of Nutritionists and Dietitians (PANAD) has its code of ethics and practice standards that its members must follow when providing clinical nutrition services for diabetes management.
The National Health Insurance Program (PhilHealth), does not cover comprehensive diabetes care, including clinical nutrition services. Due to the lack of comprehensive insurance coverage, most diabetes patients in the Philippines have to pay high out-of-pocket expenses for clinical nutrition services and other diabetes care. The fragmented healthcare system and limited access to specialized diabetes care in the Philippines make it difficult for patients to consistently receive clinical nutrition services as part of their diabetes management

Competitive Landscape

Key Players

Here are some of the major key players in the Philippines Clinical Nutrition for Diabetes Care Market:

• Abbott Nutrition
• United Laboratories, Inc. (Unilab)
• Fresenius Kabi
• Nestlé S.A.
• Zemaica Healthcare
• Best Source Nutrition Pvt. Ltd.
• Sanofi
• Pascual Laboratories, Inc.
• Zuellig Pharma
• Novo Nordisk